The present invention is that at least 20% of the total pore volume is composed of pores having an average diameter of 2 to 200 nm and / or the particles are micropores having a diameter of 2 nm or less and small diameters of 50 nm to 500 nm. Porous carbon particles for use in the treatment or prevention of liver disease that contain macropores but are substantially free of mesopores with a diameter greater than 2 nm and less than 50 nm and large macropores with a diameter greater than 500 nm I will provide a. [Selection figure] None本発明は、全細孔容積の少なくとも20%は、2～200nmの平均直径を有する細孔から構成され、及び/又は該粒子は、直径が2nm以下のマイクロポア及び直径が50nm～500nmの小さなマクロポアを含むが、直径が2nmを超え且つ50nm未満のメソポアを実質上含まず、及び直径が500nmを超える大きなマクロポアを実質上含まない、肝疾患の治療又は予防において使用するための多孔性炭素粒子を提供する。【選択図】なし
